Hope O'Brien
Neurology with Special Qualifications in Child Neurology · Cincinnati, OHNPI 1972704138
Payments from drug & device makers
Across 774 payments — averaging $1276.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$453K
- Eli Lilly$119K
- Pfizer$115K
- Lilly USA, LLC$77K
- Ipsen Innovation$68K
- Biohaven Pharmaceuticals, Inc.$46K
- plus $110K from 22 others
Across 10 payments — averaging $3229.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$20K
- AbbVie$8K
- Pfizer$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 321 | $452,909 |
| Eli Lilly | 27 | $119,223 |
| Pfizer | 96 | $114,732 |
| Lilly USA, LLC | 107 | $77,289 |
| Ipsen Innovation | 65 | $67,809 |
| Biohaven Pharmaceuticals, Inc. | 46 | $45,818 |
| Merz Pharmaceuticals, LLC | 4 | $33,500 |
| Biohaven Pharmaceutical Holding Company Ltd. | 23 | $23,850 |
| Axsome Therapeutics, Inc. | 18 | $15,571 |
| Biodelivery Sciences International, Inc. | 14 | $12,020 |
| Amgen | 8 | $10,537 |
| Bausch Health US, LLC | 3 | $4,125 |
| Teva Pharmaceuticals USA, Inc. | 8 | $3,395 |
| Scilex Pharmaceuticals Inc. | 3 | $2,436 |
| Ipsen Biopharm Limited | 1 | $2,385 |
| Collegium Pharmaceutical, Inc. | 2 | $917 |
| Tonix Medicines, Inc. | 2 | $527 |
| SK Life Science, Inc. | 6 | $263 |
| AstraZeneca | 2 | $210 |
| Lundbeck LLC | 5 | $179 |
| Janssen Scientific Affairs, LLC | 1 | $130 |
| Gynesonics, Inc. | 1 | $124 |
| Impel Pharmaceuticals LLC | 3 | $56 |
| Impel Pharmaceuticals Inc. | 3 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$988,160 in reported general payments places this provider in the 90th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Other neurology with special qualifications in child neurology in Cincinnati
- Andrew HersheyCincinnati$2M
- Marielle SamahaCincinnati$1.3M
- Cuixia TianCincinnati$1.2M
- Jamie CapalCincinnati$850K
- Shannon StandridgeCincinnati$843K
- Gewalin AungaroonCincinnati$363K
- David RitterCincinnati$184K
- Alexander ZygmuntCincinnati$171K
- Tracy GlauserCincinnati$130K
- Darcy KruegerCincinnati$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.